» Articles » PMID: 8494359

Activities of Fluoroquinolone, Macrolide, and Aminoglycoside Drugs Combined with Inhibitors of Glycosylation and Fatty Acid and Peptide Biosynthesis Against Mycobacterium Avium

Overview
Specialty Pharmacology
Date 1993 Apr 1
PMID 8494359
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Smooth- and rough-colony variants of Mycobacterium avium serovar 4 were treated with three classes of drugs. The drugs were chosen for their potential inhibitory effects on the biosynthesis of the cell envelope-associated serovar-specific glycopeptidolipid antigens. Growth was monitored radiometrically with a BACTEC 460-TB instrument, and MICs were determined for each drug. Both variants were then treated with inhibitory drugs in combination with antimicrobial agents that have demonstrated effectiveness against M. avium. No growth inhibition was observed with 6-fluoro-6-deoxy-D-glucose or avidin. Inhibitors of glycosylation, i.e., 2-deoxy-D-glucose, bacitracin, and ethambutol, were inhibitory to smooth- and rough-colony variants, whereas drugs that inhibit peptide synthesis, i.e., N-carbamyl-L-isoleucine and m-fluoro-phenylalanine, were more inhibitory for the rough-colony variant. Cerulenin, which affects fatty acid synthesis, was inhibitory for both variants, but it appeared to be more effective at inhibiting the growth of the smooth-colony variant at equivalent concentrations. Generally, when inhibitors of glycosylation were used with sparfloxacin and amikacin, a synergistic effect was observed for only the smooth variant. When drugs that affect peptide synthesis were used in combination with amikacin, a synergistic effect was observed for the rough variant, and when cerulenin was used in combination with sparfloxacin or amikacin, a synergistic effect was observed for both variants. Lipid analysis revealed that although the rough variant lacks the serovar-specific glycopeptidolipid antigens, it does possess a group of phenylalanine-isoleucine-containing lipopeptides that may explain its different susceptibility patterns to m-fluoro-phenylalanine and N-carbamyl-L-isoleucine. The significance of these results is discussed with reference to various components in the cell envelope and their importance in cell wall permeability.

Citing Articles

Warm, Sweetened Milk at the Twilight of Immunity - Alzheimer's Disease - Inflammaging, Insulin Resistance, and Immunosenescence.

Dow C Front Immunol. 2021; 12:714179.

PMID: 34421917 PMC: 8375433. DOI: 10.3389/fimmu.2021.714179.


On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease.

Juste R, Elguezabal N, Garrido J, Pavon A, Geijo M, Sevilla I PLoS One. 2008; 3(7):e2537.

PMID: 18596984 PMC: 2434204. DOI: 10.1371/journal.pone.0002537.


On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosis.

Greenstein R, Su L, Juste R, Brown S PLoS One. 2008; 3(6):e2496.

PMID: 18575598 PMC: 2427180. DOI: 10.1371/journal.pone.0002496.


Genes required for intrinsic multidrug resistance in Mycobacterium avium.

Philalay J, Palermo C, Hauge K, Rustad T, Cangelosi G Antimicrob Agents Chemother. 2004; 48(9):3412-8.

PMID: 15328105 PMC: 514743. DOI: 10.1128/AAC.48.9.3412-3418.2004.


Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.

Rastogi N, Goh K, Bryskier A, Devallois A Antimicrob Agents Chemother. 1996; 40(11):2483-7.

PMID: 8913450 PMC: 163561. DOI: 10.1128/AAC.40.11.2483.


References
1.
Draper P, Rees R . The nature of the electron-transparent zone that surrounds Mycobacterium lepraemurium inside host cells. J Gen Microbiol. 1973; 77(1):79-87. DOI: 10.1099/00221287-77-1-79. View

2.
Nomura S, Horiuchi T, Omura S, Hata T . The action mechanism of cerulenin. I. Effect of cerulenin on sterol and fatty acid biosynthesis in yeast. J Biochem. 1972; 71(5):783-96. DOI: 10.1093/oxfordjournals.jbchem.a129827. View

3.
Draper P . The mycoside capsule of Mycobacterium Avium 357. J Gen Microbiol. 1974; 83(2):431-3. DOI: 10.1099/00221287-83-2-431. View

4.
Kim K, Salton M, Barksdale L . Ultrastructure of superficial mycosidic integuments of Mycobacterium sp. J Bacteriol. 1976; 125(2):739-43. PMC: 236136. DOI: 10.1128/jb.125.2.739-743.1976. View

5.
Omura S . The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bacteriol Rev. 1976; 40(3):681-97. PMC: 413976. DOI: 10.1128/br.40.3.681-697.1976. View